Icad Inc (NASDAQ: ICAD) kicked off on Monday, up 17.77% from the previous trading day, before settling in for the closing price of $2.42. Over the past 52 weeks, ICAD has traded in a range of $1.18-$2.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -11.41% over the past five years. While this was happening, its average annual earnings per share was recorded 15.41%. With a float of $25.05 million, this company’s outstanding shares have now reached $26.35 million.
Let’s look at the performance matrix of the company that is accounted for 69 employees. In terms of profitability, gross margin is 85.32%, operating margin of -32.31%, and the pretax margin is -27.87%.
Icad Inc (ICAD) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Icad Inc is 5.63%, while institutional ownership is 22.84%.
Icad Inc (ICAD) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.00% during the next five years compared to 11.68% growth over the previous five years of trading.
Icad Inc (NASDAQ: ICAD) Trading Performance Indicators
Take a look at Icad Inc’s (ICAD) current performance indicators. Last quarter, stock had a quick ratio of 3.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of Icad Inc (ICAD)
Icad Inc (NASDAQ: ICAD) saw its 5-day average volume 0.96 million, a positive change from its year-to-date volume of 0.44 million. As of the previous 9 days, the stock’s Stochastic %D was 79.55%. Additionally, its Average True Range was 0.22.
During the past 100 days, Icad Inc’s (ICAD) raw stochastic average was set at 87.32%, which indicates a significant increase from 83.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.04% in the past 14 days, which was higher than the 92.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.89, while its 200-day Moving Average is $1.62. Nevertheless, the first resistance level for the watch stands at $3.12 in the near term. At $3.39, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.72. If the price goes on to break the first support level at $2.53, it is likely to go to the next support level at $2.20. The third support level lies at $1.93 if the price breaches the second support level.
Icad Inc (NASDAQ: ICAD) Key Stats
The company with the Market Capitalisation of 75.64 million has total of 26,540K Shares Outstanding. Its annual sales at the moment are 17,320 K in contrast with the sum of -4,850 K annual income. Company’s last quarter sales were recorded 4,220 K and last quarter income was -1,800 K.
